Matches in Wikidata for { <http://www.wikidata.org/entity/Q92751794> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q92751794 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92751794 description "bài báo khoa học" @default.
- Q92751794 description "scientific article published on 01 April 2019" @default.
- Q92751794 description "wetenschappelijk artikel" @default.
- Q92751794 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q92751794 name "Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q92751794 name "Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q92751794 type Item @default.
- Q92751794 label "Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q92751794 label "Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q92751794 prefLabel "Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q92751794 prefLabel "Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q92751794 P1433 Q92751794-B778A03B-F39D-4AF2-A023-1B479223B67D @default.
- Q92751794 P1476 Q92751794-1DCB4FD7-609F-43AE-BC0E-EDD81360F928 @default.
- Q92751794 P2093 Q92751794-07B33DF6-7EE5-4E43-910C-19967C13B555 @default.
- Q92751794 P304 Q92751794-58144CF3-3285-4159-936D-6FAC6F123F6D @default.
- Q92751794 P31 Q92751794-6D73941C-294F-4B86-A9F4-324B583BA61F @default.
- Q92751794 P356 Q92751794-7A9D69EB-08AF-43C6-B2AB-18A66EB3E8C3 @default.
- Q92751794 P433 Q92751794-EE5C157A-7B10-4672-920D-D233248E5DA2 @default.
- Q92751794 P478 Q92751794-9D226AD1-C71C-49AF-881A-D5AEFA3B239D @default.
- Q92751794 P577 Q92751794-950DCA35-5033-4F10-B69E-23ECD4F0A164 @default.
- Q92751794 P698 Q92751794-8F7B24E9-EE9C-4DAC-8724-2FB404EFAB69 @default.
- Q92751794 P921 Q92751794-CCA85124-DF59-493E-B49F-3A0EF00BB622 @default.
- Q92751794 P356 CNCR.32088 @default.
- Q92751794 P698 30934124 @default.
- Q92751794 P1433 Q326041 @default.
- Q92751794 P1476 "Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q92751794 P2093 "Carrie Printz" @default.
- Q92751794 P304 "1213" @default.
- Q92751794 P31 Q13442814 @default.
- Q92751794 P356 "10.1002/CNCR.32088" @default.
- Q92751794 P433 "8" @default.
- Q92751794 P478 "125" @default.
- Q92751794 P577 "2019-04-01T00:00:00Z" @default.
- Q92751794 P698 "30934124" @default.
- Q92751794 P921 Q412616 @default.